GBA and APOE ε4 Associate with Sporadic Dementia with Lewy Bodies in European Genome Wide Association Study

Dementia with Lewy Bodies (DLB) is a common neurodegenerative disorder with poor prognosis and mainly unknown pathophysiology. Heritability estimates exceed 30% but few genetic risk variants have been identified. Here we investigated common genetic variants associated with DLB in a large European multisite sample. We performed a genome wide association study in Norwegian and European cohorts of 720 DLB cases and 6490 controls and included 19 top-associated single-nucleotide polymorphisms in an additional cohort of 108 DLB cases and 75545 controls from Iceland. Overall the study included 828 DLB cases and 82035 controls. Variants in the ASH1L/GBA (Chr1q22) and APOE ε4 (Chr19) loci were associated with DLB surpassing the genome-wide significance threshold (p < 5 × 10). One additional genetic locus previously linked to psychosis in Alzheimer's disease, ZFPM1 (Chr16q24.2), showed suggestive association with DLB at p-value < 1 × 10. We report two susceptibility loci for DLB at genome-wide significance, providing insight into etiological factors. These findings highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.

Citing Articles

The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.

Rosal A, Martin S, Strafella A Front Neurosci. 2025; 19:1515374.

PMID: 40052092 PMC: 11882537. DOI: 10.3389/fnins.2025.1515374.

Polygenic risk discriminates Lewy body dementia from Alzheimer's disease.

McKeever A, Swann P, Malpetti M, Donaghy P, Thomas A, Mak E Alzheimers Dement. 2025; 21(2):e14381.

PMID: 39853853 PMC: 11848393. DOI: 10.1002/alz.14381.

Epigenetic Modifiers: Exploring the Roles of Histone Methyltransferases and Demethylases in Cancer and Neurodegeneration.

Reed L, Abraham J, Patel S, Dhar S Biology (Basel). 2025; 13(12.

PMID: 39765675 PMC: 11673268. DOI: 10.3390/biology13121008.

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Shiner T, Kave G, Mirelman A, Regev K, Piura Y, Goldstein O Mov Disord. 2024; 39(12):2280-2285.

PMID: 39212252 PMC: 11657010. DOI: 10.1002/mds.30003.

Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases.

Scalco R, Oliveira L, Lai Z, Harvey D, Abujamil L, DeCarli C Acta Neuropathol Commun. 2024; 12(1):134.

PMID: 39154006 PMC: 11330038. DOI: 10.1186/s40478-024-01827-7.

References

Tsuang D, Leverenz J, Lopez O, Hamilton R, Bennett D, Schneider J . APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013; 70(2):223-8. PMC: 3580799. DOI: 10.1001/jamaneurol.2013.600. View

Lemstra A, de Beer M, Teunissen C, Schreuder C, Scheltens P, van der Flier W . Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2016; 88(2):113-118. DOI: 10.1136/jnnp-2016-313775. View

Zheng X, Demirci F, Barmada M, Richardson G, Lopez O, Sweet R . Genome-wide copy-number variation study of psychosis in Alzheimer's disease. Transl Psychiatry. 2015; 5:e574. PMC: 4490277. DOI: 10.1038/tp.2015.64. View

Farrer M, Kachergus J, Forno L, Lincoln S, Wang D, Hulihan M . Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol. 2004; 55(2):174-9. DOI: 10.1002/ana.10846. View

Myers A, Kaleem M, Marlowe L, Pittman A, Lees A, Fung H . The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet. 2005; 14(16):2399-404. DOI: 10.1093/hmg/ddi241. View

Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D . Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord. 2012; 34(1):1-6. DOI: 10.1159/000339590. View

Seto-Salvia N, Clarimon J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O . Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol. 2011; 68(3):359-64. DOI: 10.1001/archneurol.2011.17. View

Nalls M, Pankratz N, Lill C, Do C, Hernandez D, Saad M . Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet. 2014; 46(9):989-93. PMC: 4146673. DOI: 10.1038/ng.3043. View

Berge G, Sando S, Rongve A, Aarsland D, White L . Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. J Neurol Neurosurg Psychiatry. 2014; 85(11):1227-31. PMC: 4215279. DOI: 10.1136/jnnp-2013-307228. View

10.

McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

11.

Oesterhus R, Soennesyn H, Rongve A, Ballard C, Aarsland D, Vossius C . Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. Dement Geriatr Cogn Disord. 2014; 38(3-4):161-9. DOI: 10.1159/000358051. View

12.

Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A . Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2016; 31(9):1075-83. DOI: 10.1002/gps.4433. View

13.

Geiger J, Ding J, Crain B, Pletnikova O, Letson C, Dawson T . Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis. 2016; 94:55-62. PMC: 4983488. DOI: 10.1016/j.nbd.2016.06.004. View

14.

Keogh M, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers K, Hussein R . Exome sequencing in dementia with Lewy bodies. Transl Psychiatry. 2016; 6:e728. PMC: 4872424. DOI: 10.1038/tp.2015.220. View

15.

Nalls M, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith I, Chinnery P . A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol. 2013; 70(6):727-35. PMC: 3841974. DOI: 10.1001/jamaneurol.2013.1925. View

16.

Brown S . Aetiology of Parkinson's disease. N Z Med J. 1997; 110(1045):216-7. View

17.

Kramer M, Schulz-Schaeffer W . Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci. 2007; 27(6):1405-10. PMC: 6673583. DOI: 10.1523/JNEUROSCI.4564-06.2007. View

18.

Guerreiro R, Ross O, Kun-Rodrigues C, Hernandez D, Orme T, Eicher J . Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol. 2017; 17(1):64-74. PMC: 5805394. DOI: 10.1016/S1474-4422(17)30400-3. View

19.

Li J, Kanekiyo T, Shinohara M, Zhang Y, LaDu M, Xu H . Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J Biol Chem. 2012; 287(53):44593-601. PMC: 3531774. DOI: 10.1074/jbc.M112.420224. View

20.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V . Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet. 2014; 23(23):6139-46. PMC: 4222357. DOI: 10.1093/hmg/ddu334. View